Detalhe da pesquisa
1.
Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial.
J Interferon Cytokine Res
; 37(11): 488-493, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29135370